An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options
Clinical trial NCT04739150 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04739150
- Sponsor
- Boehringer Ingelheim
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.